Recipient Site Pre-conditioning in Fat Grafting (me15Schaefer)

  • End date
    Jan 24, 2023
  • participants needed
  • sponsor
    University Hospital, Basel, Switzerland
Updated on 24 March 2022


This study aims to investigate the preparation of the recipient site prior to autologous fat grafting (AFG) using different methods.


Autologous fat grafting is emerging as a powerful tool for soft tissue reconstruction and augmentation and is widely used in plastic surgery. However, there is great variability in terms of long-term graft retention (survival). Moreover, the recipient site preparation is the phase of the procedure which received less attention in clinical and pre-clinical investigations. To provide information regarding an effective preparation of the recipient site may potentially lead to improvements in fat graft survival.

Condition Graft Loss, Condition
Treatment pre-expansion using Kiwi® VAC-6000M., pre-heating using Hilotherm Calido®., pre-expansion-heating
Clinical Study IdentifierNCT03393598
SponsorUniversity Hospital, Basel, Switzerland
Last Modified on24 March 2022


Yes No Not Sure

Inclusion Criteria

Informed Consent as documented by signature
Patients presenting with contracted scars or body contouring deformities, especially as a result of previous radiation therapy or infection, in and around the breast
Body mass index superior than 18.5

Exclusion Criteria

Need for antiplatelets drugs in the 5 days before surgery and 3 days after
Known or suspected non-compliance, drug or alcohol abuse
Inability to follow the procedures of the study due to language problems, psychological disorders, dementia of the participant
Previous enrolment into the current study
Enrolment of the investigator, his or her family members, employees and other dependent persons
Patients with haemorrhagic diatheses
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note